» Articles » PMID: 34054246

Evaluation of Potency of the Selected Bioactive Molecules from Indian Medicinal Plants with M of SARS-CoV-2 Through in Silico Analysis

Overview
Publisher Elsevier
Date 2021 May 31
PMID 34054246
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The recent outbreak of the novel SARS-CoV-2 across the globe and the absence of specific drug against this virus lead the scientific community to look into some alternative indigenous treatments. India as a hub of Ayurvedic and medicinal plants can shed light on its treatment using specific active bio-molecules from these plants.

Objectives: Keeping our herbal resources in mind, we were interested to inquire whether some phytochemicals from Indian spices and medicinal plants can be used as alternative therapeutic agents in contrast to synthetic drugs.

Materials And Methods: We used molecular docking approach to test whether bioactive molecules of herbal origin such as hyperoside, nimbaflavone, ursolic acid, 6-gingerol, 6-shogaol and 6-paradol, curcumin, catechins and epigallocatechin, α-Hederin, piperine could bind and potentially block the Menzyme of the SARS-CoV-2 virus.

Results: Ursolic acid showed the highest docking score (-8.7 kcal/mol) followed by hyperoside (-8.6 kcal/mol), α-Hederin (-8.5 kcal/mol) and nimbaflavone (-8.0 kcal/mol). epigallocatechin, catechins, and curcumin also exhibited high binding affinity (Docking score -7.3, -7.1 and -7.1 kcal/mol) with the M. The remaining tested phytochemicals exhibited moderate binding and inhibitory effects.

Conclusion: This finding provides a basis for biochemical assay of tested bioactive molecules on SARS-CoV-2 virus.

Citing Articles

Investigating new drugs from marine seaweed metabolites for cervical cancer therapy by molecular dynamic modeling approach.

Islam S, Ahmed S, Mahfuj S, Das G, Tareq M, Almehmadi M Sci Rep. 2025; 15(1):3866.

PMID: 39890793 PMC: 11785738. DOI: 10.1038/s41598-024-82043-0.


Plausibility of natural immunomodulators in the treatment of COVID-19-A comprehensive analysis and future recommendations.

Akter R, Rahman M, Ahmed Z, Afrose A Heliyon. 2023; 9(6):e17478.

PMID: 37366526 PMC: 10284624. DOI: 10.1016/j.heliyon.2023.e17478.


Exploring the pharmacological aspects of natural phytochemicals against SARS-CoV-2 Nsp14 through an in silico approach.

De A, Bhattacharya S, Debroy B, Bhattacharya A, Pal K In Silico Pharmacol. 2023; 11(1):12.

PMID: 37131867 PMC: 10141836. DOI: 10.1007/s40203-023-00143-7.


Food Plant Secondary Metabolites Antiviral Activity and Their Possible Roles in SARS-CoV-2 Treatment: An Overview.

Giordano D, Facchiano A, Carbone V Molecules. 2023; 28(6).

PMID: 36985442 PMC: 10058909. DOI: 10.3390/molecules28062470.


.

Dushenkov B, Dushenkova A Paemi Sino. 2022; 24(1):113-122.

PMID: 36225268 PMC: 9553026. DOI: 10.25005/2074-0581-2022-24-1-113-122.


References
1.
Hegyi A, Ziebuhr J . Conservation of substrate specificities among coronavirus main proteases. J Gen Virol. 2002; 83(Pt 3):595-599. DOI: 10.1099/0022-1317-83-3-595. View

2.
Wang Z, Chen X, Lu Y, Chen F, Zhang W . Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 2020; 14(1):64-68. DOI: 10.5582/bst.2020.01030. View

3.
Ma C, Sacco M, Hurst B, Townsend J, Hu Y, Szeto T . Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. Cell Res. 2020; 30(8):678-692. PMC: 7294525. DOI: 10.1038/s41422-020-0356-z. View

4.
Jones G, Willett P, Glen R, Leach A, Taylor R . Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 1997; 267(3):727-48. DOI: 10.1006/jmbi.1996.0897. View

5.
Chopra G, Samudrala R . Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform. Curr Pharm Des. 2016; 22(21):3109-23. PMC: 6376875. DOI: 10.2174/1381612822666160325121943. View